“In the latest LCGC North America high performance liquid chromatography (HPLC) column survey (1), over 95% of all respondents used reversed-phase chromatography in their daily work. The popularity of this technique is undoubtedly due to its versatility. Reversed-phase chromatography can separate nonpolar, polar, ionizable, and ionic compounds, sometimes at the same time. For mobile phases, reversed-phase chromatography uses water (often buffered) and a water-miscible organic solvent; both are relatively plentiful in most parts of the world in HPLC-grade purity…”

A Leading Global Agency based in Central London has the fantastic opportunity for a talented Senior Medical Writer to join their hugely successful team.
As a Senior Writer you will enjoy the responsibility of leading the editorial development and co-ordination of a small and dedicated project team of writers inputting into a range of healthcare materials. This is an excellent opportunity for an already experienced Medical Writer to enjoy more responsibility and strategic input into the development of a team.

Genetown Career Fair
Thursday, June 10, 2010
11am to 4pm
Sheraton Boston
Boston, MA

Pre-Register Now: http://news2.biospace.com/ct.html?rtr=on&s=7cmna,dawx,mog,l564,fmqo,i4×5,47tn

Attend the Genetown Career Fair!
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region.

————–
Editor’s Comments: They used to be a great company when they were Astra. But it seems like they have become another greedy corporate entity. Zeneca changed their direction.

*Director, Laboratory Operations Support Services (Ontario)

*Process Engineer (California)

*Senior Director, Applications Development (California)

The BIO Career Fair will be held on May 3rd in conjunction with the 2010 BIO International Convention, May 3-6 in Chicago.

The BIO Career Fair is intended for professionals in the bioscience industry. Job seekers can spend the afternoon with regional, national, and international HR Representatives and hiring managers from top biotech, pharmaceutical and medical device companies who are looking to hire
talent in various fields and levels.

Who Should Attend?
Candidates with a 4-year life science degree or a community college biotech degree are invited to
attend. To register, visit:
http://news2.biospace.com/ct.html?rtr=on&s=7cmna,coil,mog,4zr4,d0s4,i4×5,47tn

What companies will be there?
The exhibitor list is growing daily. Current exhibitors include:

- Abbott
- Astellas Pharma US
- Baxter International, Inc.
- Bayer CropScience
- Biogen Idec
- COOK Pharmica
- Covance
- Eli Lilly and Company
- GE Healthcare
- Genetic Engineering & Biotechnology News
- Gilead Sciences, Inc.
- Hospira
- Human Genome Sciences, Inc.
- Illumina
- Integrated Project Management Co., Inc.
- Kelly Scientific Resources
- Meridian Bioscience, Inc.
- Monsanto
- Naturejobs
- New Scientist Jobs
- Novo Nordisk
- Pfizer, Inc.
- Pioneer Hi-Bred, a DuPont business
- Regeneron Pharmaceuticals, Inc.
- SAIC-Frederick, Inc.
- Science Careers
- Takeda Pharmaceuticals North America, Inc.
- TalentScotland
- United States Food and Drug Administration
- Valent BioSciences Corporation
- Watson Pharmaceuticals, Inc.

_________________________________

Q4B Evaluation and Recommendation
of Pharmacopoeial Texts for Use in the ICH Regions
Annex 7
Dissolution Test General Chapter

“The initiative involves two interrelated scientific disciplines: translational science, the shaping of basic scientific discoveries into treatments; and regulatory science, the development and use of new tools, standards and approaches to more efficiently develop products and to more effectively evaluate product safety, efficacy and quality. Both disciplines are needed to turn biomedical discoveries into products that benefit people.”

“As part of the effort, the agencies will establish a Joint NIH-FDA Leadership Council to spearhead collaborative work on important public health issues. The Joint Leadership Council will work together to help ensure that regulatory considerations form an integral component of biomedical research planning, and that the latest science is integrated into the regulatory review process…more“

*Senior Director, Analytical Technical Support (Pennsylvania)

*Director, Laboratory Operations Support Services (Ontario)

*Process Engineer (California)

http://www.usp.org/USPNF/recall.html

USP 32–NF 27 is official at this time and remains official until further notice. USP 33–NF 28, which was released on November 1, 2009 and recalled on January 8, 2010, was not scheduled to become official until May 1, 2010 and should not be used. The current official standards in USP 32–NF 27 can be used with confidence.

Reason for Recall

USP recalled USP 33–NF 28 because of errors that occurred when monographs were redesigned into a new format. The redesign was intended to improve ease of use, streamline presentation, and update and harmonize terminology, but was not intended to change any of the monograph requirements. The effort was comprehensive: all of the ~4000 monographs in the USP 33–NF 28 were redesigned, encompassing more than 4100 pages, over 4 million words, and many figures and tables. While many of the monographs were successfully redesigned, a significant number contained errors.

While USP has an Errata process for issuing corrections to USP–NF on an on–going basis, this process was inadequate to address the number of errors resulting from the redesign. Because maintaining the integrity and accuracy of its standards is of paramount importance, USP recalled USP 33–NF 28 in its entirety.